GPT-Rosalind
Specialized OpenAI reasoning model designed for life sciences research, drug discovery, genomics, and chemistry. The first model in the Life Sciences series.
Technical specification
Modalities
Capabilities
5Reasoning★
Reasoning
Multi-step reasoning★
Reasoning
Planning★
Planning
Structured output★
Structured gen.
Function Calling
Planning
Architecture and technologies
Core Architecture
1Form / Family
1Training Techniques
2Applications
Pricing
No public pricing
During the research preview phase, usage does not draw from existing API credits or tokens (subject to abuse-prevention limits). OpenAI has stated that pricing details and broader availability will be announced once the preview phase concludes.
Security and enterprise
The model is available exclusively to qualified corporate clients in the US under the Trusted Access program. Organizations must pass a security review covering three criteria: (1) conducting legitimate scientific research with clear public benefit, (2) having appropriate governance, regulatory compliance, and abuse prevention procedures, and (3) restricting access to approved users in secure environments. OpenAI has built in systems to detect potentially harmful activity. The access restrictions are a direct response to researcher warnings about the potential misuse of biological models for designing dangerous pathogens.
Technical information
Organizations requesting access should use the form: https://openai.com/form/life-sciences-access/